← Back to Search

Behavioral Activation and Exposure Therapy for Anxiety and Depression in Youth

N/A

Recruiting

Led By Brian C Chu, Ph.D.

Research Sponsored by Rutgers University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Major Depression Disorder (MDD)

Separation Anxiety Disorder (SEP)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from pre-treatment to post-treatment (baseline to 14-weeks)

Awards & highlights

Study Summary

This trial will compare the effectiveness of different psychological treatments for anxiety and depression in youth, as well as how well each treatment works to change specific aspects related to the disorders.

Who is the study for?

This trial is for young people aged 9-17 with anxiety or depression disorders, including Generalized Anxiety Disorder, Separation Anxiety Disorder, Social Phobia, Specific Phobia, Panic Disorder, Agoraphobia, Major Depression Disorder and other depressive conditions.Check my eligibility

What is being tested?

The study compares Individual Behavioral Activation Therapy (IBAT) to two specific psychological programs (Coping Cat for anxiety and PASCET for depression), as well as a waitlist control group to see which is more effective in treating youth with these mental health issues.See study design

What are the potential side effects?

Since the interventions are psychological therapies rather than medications, traditional side effects are not expected. However participants may experience emotional discomfort discussing personal issues during therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with Major Depression Disorder.

Select...

I have been diagnosed with separation anxiety disorder.

Select...

I have been diagnosed with Social Anxiety Disorder.

Select...

I have been diagnosed with Persistent Depressive Disorder.

Select...

I have been diagnosed with Generalized Anxiety Disorder.

Select...

I have been diagnosed with Panic Disorder.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from pre-treatment to post-treatment (baseline to 14-weeks)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from pre-treatment to post-treatment (baseline to 14-weeks)

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from pre-treatment to post-treatment (baseline to 14-weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Clinical Global Impression Severity (CGIS) Scale: Independent Evaluator

Secondary outcome measures

Change in Behavioral Activation

Child Automatic Thoughts Scale-Negative/Positive

Trial Design

2Treatment groups

Experimental Treatment

Group I: Principal Depressive DisorderExperimental Treatment3 Interventions

Youth with a principal unipolar depressive disorder

Group II: Principal Anxiety DisorderExperimental Treatment3 Interventions

Youth with a principal anxiety disorder

0 / 6Eligibility criteria met

Find a Location

Who is running the clinical trial?

Rutgers UniversityLead Sponsor

113 Previous Clinical Trials

2,803,893 Total Patients Enrolled

2 Trials studying Anxiety Disorders

1,295 Patients Enrolled for Anxiety Disorders

Brian C Chu, Ph.D.Principal InvestigatorRutgers University (Youth Anxiety and Depression Clinic)

2 Previous Clinical Trials

1,295 Total Patients Enrolled

2 Trials studying Anxiety Disorders

1,295 Patients Enrolled for Anxiety Disorders

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible for participation in this clinical investigation?

"This medical trial is looking to recruit approximately 200 youngsters with anxiety disorders who are between the ages of 9 and 17."

Answered by AI

Is this experiment still welcoming participants?

"Affirmative, clinicaltrials.gov reveals that this medical trial is currently searching for patients. It was originally posted on February 1st 2018 and updated most recently on November 15th 2023. The study necessitates 200 recruits from a single centre."

Answered by AI

Are adult participants eligible for the research program?

"This particular trial is specifically for minors between the age of 9 to 17. In total, 312 clinical trials are available that cater to people below 18 years old and 1153 studies target individuals over 65."

Answered by AI

What is the enrollment number for this medical experiment?

"Indeed, according to information on clinicaltrials.gov this trial is currently searching for participants. It was originally posted on February 1st 2018 with the most recent edit being made November 15th 2023. The medical study requires 200 individuals from a single site."

Answered by AI

Recent research and studies

New England Journal of MedicineJournal

Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety

Walkup, John T., Anne Marie Albano, John Piacentini, Boris Birmaher, Scott N. Compton, Joel T. Sherrill, Golda S. Ginsburg, et al.. 2008. “Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety”. New England Journal of Medicine. Massachusetts Medical Society. doi:10.1056/nejmoa0804633.

Journal of the American Academy of Child & Adolescent PsychiatryJournal

The Service Assessment for Children and Adolescents (SACA): Adult and Child Reports

STIFFMAN, ARLENE RUBIN, SARAH McCUE HORWITZ, KIMBERLY HOAGWOOD, WILSON COMPTON III, LINDA COTTLER, DONNA L. BEAN, WILLIAM E. NARROW, and JOHN R. WEISZ. 2000. “The Service Assessment for Children and Adolescents (SACA): Adult and Child Reports”. Journal of the American Academy of Child & Adolescent Psychiatry. Elsevier BV. doi:10.1097/00004583-200008000-00019.

Behaviour Research and TherapyJournal

Distress Tolerance and Early Adolescent Externalizing and Internalizing Symptoms: The Moderating Role of Gender and Ethnicity

Daughters, Stacey B., Elizabeth K. Reynolds, Laura MacPherson, Christopher W. Kahler, Carla K. Danielson, Michael Zvolensky, and C.W. Lejuez. 2009. “Distress Tolerance and Early Adolescent Externalizing and Internalizing Symptoms: The Moderating Role of Gender and Ethnicity”. Behaviour Research and Therapy. Elsevier BV. doi:10.1016/j.brat.2008.12.001.

Journal of Personality AssessmentJournal